GLOBAL-HEALTHCARE-EXCHNG
Global Healthcare Exchange, LLC (GHX) today announced a pan-European eInvoicing solution designed to help healthcare suppliers meet electronic invoicing regulations. With the new GHX eInvoicing, suppliers can issue and send compliant invoices to healthcare provider customers and governments across Europe from one connection.
The GHX solution, which works with the GHX Exchange Services, supports the eInvoicing requirements for integrity, authenticity, legibility and archiving under the VAT Directive 2006/112/ED and the Electronic Invoice Directive 2010/45/EU. It also provides an easy-to-use portal for customers to access invoices electronically, even those with no EDI capabilities.
“Moving away from paper invoices and manual invoicing processes will be an advantage for healthcare suppliers across Europe. However, navigating through the complexity of the European marketplace and complying with the various regulations of the EU member states can be a significant challenge,” said Dr. Nedzad Fajic, president, GHX Europe. “The new GHX eInvoicing solution with its eInvoicing portal will deliver better visibility into the entire order-to-cash cycle, reduce manual processing and help suppliers deliver a better customer experience.”
By November 27, 2018, all EU countries are required to adopt Directive 2014/55/EU into local law, which calls for all invoices sent to hospitals to have ‘authenticity of origin, content integrity and eligibility’ by having business controls and/or electronic invoicing technology in place. GHX eInvoicing is designed to meet those requirements with a simple and efficient solution.
eInvoices will be sent through a supplier’s existing GHX Global Exchange connection and checked to validate content is in the required fields. The eInvoice will then be delivered to the relevant customers and government access points across Europe, with digital signatures and archiving where required for compliance. Non-EDI capable customers will also be able to receive invoices through the new eInvoicing portal, where they can manage and retrieve invoices in PDF format, as well as receive them via email.
The new eInvoicing solution includes:
- Enabling any electronic invoice to be converted in the appropriate format with the appropriate information to comply with EU country-specific invoicing regulations.
- Interoperates with the GHX Global Exchange and other GHX solutions for the full order-to-cash cycle to provide a one-stop solution for eInvoicing in Europe.
- Automatically sends the compliant invoice to the appropriate public administration access point, as well as the appropriate customers.
- A dedicated online portal that allows even non-EDI capable customers to see and download invoices.
- Provides suppliers and their customers with access to current and past invoices all in one place.
- Includes tracking and monitoring capabilities.
Availability
GHX eInvoicing is now generally available across Europe. For more information, contact Marcus Schiewe, Head of Supplier Sales, Europe, +49 (0) 211 301 88 300.
About GHX Europe
Global Healthcare Exchange, LLC (GHX), with its European headquarters in Brussels, drives costs out of healthcare with cloud-based supply chain management technology and services to help enable better patient care and savings by maximizing automation, efficiency, and accuracy of business processes. GHX offers European healthcare providers and suppliers an open and neutral electronic trading exchange that delivers procurement and accounts payable automation as well as other supply chain-related tools and services. For more information, visit www.ghx.com/europe/en and The Healthcare Hub .
View source version on businesswire.com: http://www.businesswire.com/news/home/20170730005001/en/
Contact:
Tier One Partners
Paula Timko, 508-826-1508
ptimko@tieronepr.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release
The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev
7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release
MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release
Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom